[1] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[2] |
JIN Shengju, ZHOU Miao, ZHANG Jianing, GE Gonghui, ZHANG Tingjian, MENG Fanhao.
Research progress in novel xanthine oxidase inhibitors and treatment of gout
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 223-228.
|
[3] |
YUE Lanxin, SHEN Pan, ZHOU Lei, HUANG Congshu, ZHOU Wei, GAO Yue.
The inhibitory effect and mechanism of Celastrol on adipogenic differentiation in 3T3-L1
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 65-73.
|
[4] |
WEI Anhua, QI Jianjun, WANG Lu, ZENG Lu, GONG Xuepeng, JIANG Ying.
Adverse drug reaction/ event caused by oral antidiabetic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1415-1420.
|
[5] |
YANG Le, XIA Dongsheng, WANG Tao.
Risks to safety of vitamin B2 injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1256-1258.
|
[6] |
CAO Lin, RAN Zheng, HOU Qiang, QIU Zuocheng, YANG Jianhua.
Chemical composition of Huatie compound and prediction of potential mechanism for prevention and treatment of hyperplasia of mammary glands
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1113-1120.
|
[7] |
DILHUMAR Dilmurat, SHI Wei, WANG Jiabo, GAO Yuan.
Research progress in safe use of Psoralea corylifolia based on evolution of toxicity/efficacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 939-945.
|
[8] |
ZHANG Qin, ZHANG Luyong, JIANG Zhenzhou.
Research progress in safety of PPAR agonists
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 950-955.
|
[9] |
SU Yuefen, ZHENG Jingrou, GONG He, XIE Guangtong, ZHANG Jie, SAI Chunmei.
Formability and mechanism of breast nodule pain-alleviating gel plaster for the treatment of breast hyperplasia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 783-790.
|
[10] |
YANG Le, XIA Dongsheng, WANG Tao.
Risks to safety of vitamin B6 injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 791-794.
|
[11] |
LIAN Yufei, QIU Xuejia, FANG Lingzhi, ZHANG Yue, LIU Hongtao, DONG Zhanjun.
One case of anaphylactic shock induced by fluticasone furoate
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 829-832.
|
[12] |
QIN Guilan, ZHOU Muzi, JI Zhaoshuai, MAO Qiantai, AI Chao.
One case of acute constipation induced by semaglutide injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 833-835.
|
[13] |
ZHU Chunwu, YU Xuejun, SUN Xin, LIU Chenghai.
Overview of hepatotoxicity of Xianling Gubao capsules
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 496-499.
|
[14] |
ZHANG Shuai, GENG Yue, WAN Liyan, JI Liwei.
Efficacy and safety of insulin degludec vs other long-acting basal insulin analogues in the treatment of type 1 diabetes
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1358-1361.
|
[15] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|